Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.50 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.50 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.46 |
| ▸ | CDA | P32320 | 2/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32666021 | 1.00 | KDM4E (1.00) | KDM4EGAAPOLBCRBNFKBP5 | |
| SCHEMBL32666023 | 1.00 | KDM4E (1.00) | KDM4EGAAPOLBCRBNFKBP5 | |
| SCHEMBL32666027 | 1.00 | KDM4E (1.00) | KDM4EGAAPOLBCRBNFKBP5 | |
| Desmethylenylnocardamine SCHEMBL32666030 | 1.00 | KDM4E (1.00) | KDM4EGAAPOLBCRBNFKBP5 | |
| Dehydroxynocardamine SCHEMBL31483973 | 1.00 | KDM4E (1.00) | KDM4EGAAPOLBCRBNFKBP5 | |
| SCHEMBL10574088 | 1.00 | KDM4E (1.00) | KDM4EGAAPOLBCRBNFKBP5 | |
| Nocardamine SCHEMBL28160236 | 0.98 | KDM4E (0.96) | KDM4EGAAPOLBCRBNFKBP5 | |
| SCHEMBL29855407 | 0.98 | KDM4E (0.96) | KDM4EGAAPOLBCRBNFKBP5 | |
| SCHEMBL32666026 | 0.98 | KDM4E (0.96) | KDM4EGAAPOLBCRBNFKBP5 | |
| SCHEMBL26818280 | 0.93 | KDM4E (0.87) | KDM4EGAAPOLBCRBNFKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4329709-B1 | COMPOSITION COMPRISING DESFERRIOXAMINES AND UV LIGHT FILTER | EVONIK OPERATIONS GMBH (DE) | 2026-01-28 | — | — | EP | claimed |
| EP-4637737-A1 | COMPOSITIONS CONTAINING BIOSURFACTANTS AND DESFERRIOXAMINES | Evonik Operations GmbH (DE) | 2025-10-29 | — | — | EP | claimed |
| EP-4626393-A1 | COMPOSITION COMPRISING DESFERRIOXAMINES AND A MIXTURE OF TRIGLYCERIDES | Evonik Dr. Straetmans GmbH (DE) | 2025-10-08 | — | — | EP | claimed |
| US-12365945-B2 | Urinary microbiomic profiling | Convergent Genomics, Inc. (US) | 2025-07-22 | — | — | US | claimed |
| US-20250009891-A1 | CONJUGATES OF MONOCYCLIC BETA-LACTAMS AND SIDEROPHORE MIMETICS | UNIVERSITY OF NOTRE DAME DU LAC | 2025-01-09 | — | — | US | claimed |
| US-20240207153-A1 | DESFERRIOXAMINES AND COMPOSITION CONTAINING UV LIGHT PROTECTION FILTERS | EVONIK DR. STRAETMANS GMBH (DE) | 2024-06-27 | — | — | US | claimed |
| WO-2024132679-A1 | COMPOSITIONS CONTAINING BIOSURFACTANTS AND DESFERRIOXAMINES | EVONIK DR. STRAETMANS GMBH (DE) | 2024-06-27 | — | — | WO | claimed |
| WO-2024115214-A1 | COMPOSITION COMPRISING DESFERRIOXAMINES AND A MIXTURE OF TRIGLYCERIDES | EVONIK DR. STRAETMANS GMBH (DE) | 2024-06-06 | — | — | WO | claimed |
| EP-4329709-A1 | DESFERRIOXAMINES AND COMPOSITION CONTAINING UV LIGHT PROTECTION FILTERS | Evonik Dr. Straetmans GmbH (DE) | 2024-03-06 | — | — | EP | claimed |
| EP-3775302-B1 | RECOVERY OF METALS FROM INDUSTRIAL WASTEWATER OF LOW METAL CONCENTRATION | HELMHOLTZ ZENTRUM DRESDEN (DE) | 2023-08-30 | — | — | EP | claimed |
| EP-3236970-B1 | NEW METAL COMPLEXES OF NOCARDAMINE AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | CHEVION MORDECHAI (IL) | 2020-12-16 | — | — | EP | claimed |
| CN-107206091-A | New complexes of nocardamine and their use in pharmaceutical compositions | 莫迪凯·舍维龙 | 2017-09-26 | — | — | CN | claimed |
| EP-2129762-B2 | SIDEROPHORE-METAL- COMPLEXES USED AS BLEACH CATALYSTS | HENKEL AG & CO KGAA (DE) | 2015-10-07 | — | — | EP | claimed |
| CN-103642723-B | Streptomyces and method for preparing two antibiotics by utilizing same | JIANGXI NORMAL UNIVERSITY (CN) | 2015-09-09 | — | — | CN | claimed |
| CN-103642723-A | Streptomyces and method for preparing two antibiotics by utilizing same | UNIV JIANGXI NORMAL | 2014-03-19 | — | — | CN | claimed |
| CN-102657644-B | Use of nocardamine in preparation of senile dementia-resisting drug | UNIV JIANGXI AGRICULTURAL | 2013-12-18 | — | — | CN | claimed |
| EP-2129762-B1 | SIDEROPHORE-METAL- COMPLEXES USED AS BLEACH CATALYSTS | HENKEL AG & CO KGAA (DE) | 2012-06-27 | — | — | EP | claimed |
| WO-2010094587-A1 | MICROBIAL SIDEROPHORE SYNTHESIS | HENKEL AG & CO. KGAA (DE) | 2010-08-26 | — | — | WO | claimed |
| EP-2129762-A1 | SIDEROPHORE-METAL- COMPLEXES USED AS BLEACH CATALYSTS | Henkel AG & Co. KGaA (DE) | 2009-12-09 | — | — | EP | claimed |
| WO-2008101909-A1 | SIDEROPHORE-METAL- COMPLEXES USED AS BLEACH CATALYSTS | HENKEL AG & CO. KGAA (DE) | 2008-08-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009891-A1 | CONJUGATES OF MONOCYCLIC BETA-LACTAMS AND SIDEROPHORE MIMETICS | MGAM, OPRM1, BPGM | KDM4E 1593/4885GAA 210/4885POLB 510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.